Intuitive Surgical, Inc. recently declared that they have acquired Orpheus Medical, a clinical solutions company providing hospitals with a clinical media platform. Intuitive Surgical Inc., which is a California-based corporation known for the da Vinci robot-assisted surgical system, aims to integrate informatics in their business development. At the J.P. Morgan Healthcare Conference in January 2020, Intuitive’s CEO Gary Guthart said that “healthcare is transforming using data,” and that his company aims to be part of this transformation.
Orpheus, which marks its tenth year in clinical video management, helps hospitals maintain, process, and archive images and videos of surgical procedures. The company was awarded the 2017 Global Frost & Sullivan Award for Product Leadership, for its developments in improving clinical workflows and care coordination. It is also used in the OLV Robotic Surgery Institute, also known as the ORSI Academy. Notably, the technology is able to record and broadcast from da Vinci robots. Aside from this, Orpheus-enabled da Vinci systems enable teleconferencing, as well as storing and sharing of content with hospital electronic records.
The informatics system can also be made compatible with the technology used in laparoscopic surgery, plastic surgery, ophthalmology, and dermatology procedures. The video management system may be used to document the start of a procedure and analyze complications that may arise mid-procedure. It can also be programmed to conduct daily peer reviews.
The da Vinci is the most widely-used robotic surgical system, with more than 5,500 units in operation worldwide. These are designed to help surgeons during minimally invasive procedures, and provide a high-definition and magnified view of the area to be dissected or reconstructed. Data-driven management decisions and analytics initiatives are among Intuitive’s top priorities for the year, and the acquisition of Orpheus has been on the table for a long time.
Julian Nikolchev, Intuitive Surgical’s senior vice president of corporate development and strategy, said in a news release that Orpheus will benefit both patients and medical teams. “The addition of Orpheus will provide customers — including surgeons, patient care teams and hospitals — with ready access to and a deeper understanding of their data, which we believe may help our customers improve patient outcomes and lower total treatment costs,” he says.
Orpheus Medical’s CEO, Gaddi Menahem, also adds that the companies’ innovations, combined with Intuitive’s reach and resources, will allow patients to have easier and faster access to their data. As with any risk, however, both companies are prepared for possible fallouts. In Intuitive’s 2018 year-end report, they highlighted the optimistic statements regarding Orpheus, and this was reiterated in the press release following their acquisition.
“This press release contains forward-looking statements, including statements regarding the company’s acquisition of Orpheus Medical. These forward-looking statements are necessarily estimates reflecting the best judgment of the company’s management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements,” the report reads.
Conclusion
Outlook seems to be positive, however, as Market Reports World estimates a compound annual growth rate of 22.75% by 2023 for the robot-assisted surgery market.
Browse our website today for more news in the medical industry.
